Cite Filings / CVKD / 0001950047-25-007483
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
144

Sale of Securities

Cadrenal Therapeutics, Inc. · Filed 2025-09-24 · Acc 0001950047-25-007483

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2025-09-26 4 Chief Financial Officer sold 12,400 shares at an average $14.05 ($174,175)
  • 2025-09-26 4 CEO and Chairman sold 9,371 shares at an average $14.06 ($131,779)
  • 2025-09-25 144 Sale of Securities
  • 2025-09-25 144 Sale of Securities
  • 2025-09-24 144 Sale of Securities
  • 2025-09-24 144 Sale of Securities
  • 2025-09-24 8-K Shareholder vote results

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…